Non destiné à la consommation humaine, à l’usage vétérinaire ou à l’administration clinique. Vendu exclusivement à des laboratoires et chercheurs qualifiés pour étude in-vitro.
BPC-157, short for Body Protection Compound-157, is a 15-amino-acid peptide originally derived from a protective protein found in human gastric juice. Over the last decade, it's become one of the most-studied research peptides in regenerative biology — particularly in models exploring how tissues recover from injury and cellular stress.
Research has explored BPC-157's role in cellular repair pathways, including angiogenic activity and modulation of growth factor signaling. Studies have investigated its effects across tendon, ligament, muscle, and intestinal tissue research models, as well as its interaction with nitric oxide pathways. Its reported gastric stability makes it a versatile candidate across different research protocols.
Researchers also explore BPC-157 in the context of gut barrier function and inflammatory pathway research. Early-stage studies examining its protective profile in gastrointestinal models have contributed to its reputation as a broadly studied pentadecapeptide in pre-clinical research.
myPEPT supplies BPC-157 as a lyophilized peptide with ≥99% verified purity, accompanied by a Certificate of Analysis from third-party lab testing. Each batch is independently verified, and we ship across the EU with research-grade packaging.
What researchers should know: BPC-157 is supplied for laboratory research use only. It is not approved for human consumption and is not a medical product. Always handle and store in line with your lab's protocols and applicable regulations in your jurisdiction.
Réservé à un usage de recherche. Ce produit est destiné exclusivement à la recherche in vitro et aux applications de laboratoire. Il n'est pas approuvé pour la consommation humaine ou animale, le traitement médical ni l'usage thérapeutique.
For research use only. This product is intended exclusively for in-vitro research and laboratory applications. Not approved for human or animal consumption, medical treatment, or therapeutic use. BPC-157 is explicitly named on the WADA Prohibited List (Section S0) since 2022. It has not received marketing authorisation from any regulatory body.


